This disclosure relates to catheter assemblies configured for use with multiple guidewires. Preferred arrangements provide for catheters assemblies with marker arrangements that are useful in visually aligning features of the catheter assembly and methods related to the same.
Catheters are used with stents and balloon inflatable structures to treat conditions such as strictures, stenoses, and narrowing in various parts of the body. Various catheter designs have been developed for the dilatation of stenoses and to deliver and deploy stents at treatment sites within the body.
Stents are typically intraluminally placed by a catheter within a vein, artery, or other tubular shaped body organ for treating conditions such as, for example, occlusions, stenoses, aneurysms, dissection, or weakened, diseased, or abnormally dilated vessel or vessel wall, by expanding the vessel or by reinforcing the vessel wall. Stents can improve angioplasty results by preventing elastic recoil and remodeling of the vessel wall and treating dissections in blood vessel walls caused by balloon angioplasty of coronary arteries.
While conventional stent technology is relatively well developed, stent technologies related to treatment of the region of a vessel bifurcation are still being developed. One challenge related to treatment of a vessel bifurcation involves alignment of the stent relative to the vessel branches of the vessel bifurcation.
The present disclosure relates to catheter assemblies having first and second catheter branches or shafts that are configured for advancement over separate guidewires to a treatment site within a patient. A given catheter assembly includes a marker configuration wherein each catheter branch can include a plurality of markers. A comparison of the position and arrangement of markers on one catheter branch relative to the position and arrangement of markers on the other catheter branch can provide a visual indication of axial and radial positioning of catheter branches relative to each other. Differences in the marker arrangements, including size, shape, and axially positioning on the catheter branches can also be helpful in visually distinguishing one catheter branch from the other.
The markers on the main and side catheter branches can be arranged in any of a plurality of arrangements that result in different marker configurations for the catheter assembly. In one example, the markers on the side catheter branch are spaced apart axially a distance greater than a spacing between the markers of the main catheter branch, and the markers of the main catheter branch are positioned at a location axially between the markers of the side catheter branch. In another example, the markers on the side catheter branch are spaced apart a distance wherein a proximal marker is spaced proximal of a proximal end of a stent carried by the catheter assembly, and a distal marker is positioned distal of the side opening of the stent. In a further example, the side catheter branch markers are spaced apart a distance at least as great as a length of the stent. The markers of the stent delivery system can also be imageably distinct from each other as a result of, for example, different markers sizes, shapes and materials.
Another aspect of the present disclosure relates to the addition of an elongate marker member to at least one of the side and main catheter branches. The elongate marker member can include a coil structure, such as a helical shaped coil, that extends along a portion of the catheter branch length. The elongate marker member can also be configured as, for example, a braid, a series of connected rings, or other structure having a shape that is non-linear relative to an axis of the catheter branch. The marker member can also be defined as part of the catheter branch material composition. The length of the elongate marker member is typically at least twice as long as common radiopaque markers used with bifurcation stent delivery systems.
There is no requirement that an arrangement include all features characterized herein to obtain some advantage according to this disclosure.
General Background
This disclosure relates to catheter assemblies configured for use with multiple guidewires. Marker bands and other marker features can be used to visually identify the various catheter branches and the relative position of the catheter branches, for example, during treatment of a vessel bifurcation. The disclosed catheter assemblies and related methods include a main catheter branch and a side catheter branch. A main balloon is typically positioned at a distal end portion of the main catheter branch. When using the catheter assemblies for delivery of a stent, the stent is also positioned on the main balloon at the distal end portion of the main catheter branch. The side catheter branch can be used to help orient the stent relative to a branch vessel at a vessel bifurcation.
Bifurcation stent delivery systems are particularly useful for treating vessel bifurcations. A bifurcation stent is typically configured to provide access through a side opening of the stent into a branch vessel of the vessel bifurcation. In some embodiments, the stent also includes extension structure that extends radially outward from the stent to at least partially into the branch vessel.
The use of multiple guidewires simultaneously within a common lumen such as a blood vessel can result in cross-over of the guidewires along their lengths and cross-over of the catheter branches that move over the guidewires. When one guidewire is directed into a branch vessel and another guidewire is maintained in the main vessel of a vessel bifurcation, cross-over or relative rotation of the catheter branches passing over those guidewires can result in misalignment of the stent relative to the opening of the branch vessel.
In some applications, such as in bifurcation stent delivery systems, features of the stent (e.g., the side opening) must be axially aligned, radially aligned, or both axially and radially aligned relative to an opening into or ostium of the branch vessel of the vessel bifurcation. If the catheter branches are rotated relative to each other, misalignment of the stent features is likely to result, thereby causing deployment of the stent at an orientation that does not provide most effective treatment of the vessel bifurcation. Identification of relative rotation between and the relative axial and radial position of the catheter branches using the example marker systems described below can provide the system operator with an understanding of the relative position of the catheter branches so that adjustments can be made prior to deploying the stent at the vessel bifurcation. In many cases, the mere distinguishing between the main and side catheter branches can result in improved treatment and correction by the operator.
The Embodiment of
An illustrated view of one embodiment of a stent delivery system 10 is shown with reference to
The main catheter branch 12 includes a main guidewire member 26, a main balloon 28, and a side balloon 30. The guidewire member 26 defines a main guidewire lumen sized to advance over the main guidewire 36. The side balloon 30 includes a proximal portion 32 that that intersects the main catheter branch 12 proximal of the main balloon 28, and a distal portion 34 that intersects the main guidewire member 26 distal of the main balloon 28. The side balloon 30 is configured to extend radially outward relative to the main balloon 28 when the side balloon 30 is inflated.
The main balloon 28 is configured to remain in a main vessel of a vessel bifurcation at an axial position that spans an opening into a branch vessel of the vessel bifurcation. The side balloon 30 is configured to expand into an opening of the branch vessel. The side balloon 30, when inflated, typically expands a portion of the stent structure that defines the side opening of the stent into the side open of the branch vessel.
Typically, the main and side balloons 28, 30 are coupled in fluid communication with a common inflation lumen that is defined in the catheter shaft 11. The common inflation lumen can be conventional, and extend distally from a proximal end of the stent delivery system that remains outside of the patient (not shown). The common inflation lumen is used to supply pressurized inflation fluid to the main and side balloons 28, 30 during inflation and drain the inflation fluid when deflating the balloons 28, 30.
The balloons 28, 30 are illustrated as separate balloons that are positioned adjacent to each other. In other balloon arrangements, the side balloon 30 is positioned on the main balloon 28. For example, the side balloon 30 can be integral with the main balloon 28, or be formed as a separate piece that is secured to the outer surface of the main balloon 30. The side balloon 30 can also be integrated into the side catheter branch 14 or another catheter branch of the catheter assembly, such as described in co-pending U.S. patent application Ser. No. 10/644,550, entitled STENT WITH A PROTRUDING BRANCH PORTION FOR BIFURCATING VESSELS. The side catheter branch 14 in this exemplary embodiment is exterior to and distinct from the main catheter branch 12.
In operation, the side catheter branch 14 extends through a sidewall opening 52 of the stent 50 (see
The markers 18, 19 and 22, 23 are shown in
Referring now to
In some cases it may be difficult for the operator to visually determine the relative alignment of markers 18, 22 in the case of steep angles β or extensive distance of the marker 22 from the stent sidewall opening 52. In such cases, it may be beneficial to provide additional markers or other types of features on one or both of the catheter branches 12, 14. The addition of extra markers can improve visualization of the positioning of the catheter branches relative to each other. Alternative marker arrangements and marker features are described in further detail below with reference to
After the stent delivery system has been positioned as shown in
Once the stent delivery system 10 is positioned with the sidewall opening 52 and auxiliary inflatable portion 34 aligned with the opening into the branch vessel 44, pressurized fluid is supplied to the main and auxiliary inflatable portions 32, 34 to dilate and expand stent 50 (see
The extendable structure 54 of the stent 50 can have a variety of configurations such as those configurations disclosed in co-pending U.S. Published Patent Application Nos. 2004/0138737 and 2005/0015108, which patent applications are incorporated herein by reference.
Alternative Marker Configurations
The markers 18 and 19 shown in
The total length of each of markers 18, 19, 22, 23 is typically in the range of about 0.5 mm to about 5 millimeters long, more preferably about 0.75 mm to about 2 millimeters long, and most preferably about 0.75 mm to about 1 millimeter long. The material composition of the markers is a consideration for the marker length, the marker material thickness, and the cross-sectional size of the markers. Typically, the materials used for the markers have a greater stiffness than the stiffness of the material of the catheter branches 12, 14 to which the markers are mounted. The use of most markers, regardless of the size and shape, can reduce to some degree the flexibility of the catheter branches to which the markers are mounted. Shortening the length of the markers can minimize negative effects on catheter flexibility. Markers that are too short can become difficult to visualize. Optimizing the size and shape of the markers to provide adequate visualization while minimizing added stiffness in the catheter is one objection of the markers and marker arrangements disclosed herein.
One option for providing the appearance of one longer marker is to position two shorter markers adjacent to each other with a small gap there between.
The markers 18, 19, 22, 23 can comprise different material compositions that provide differing amounts of visualization of the marker, stiffness, ease of handling and forming of the marker, and other considerations. Some example materials used in the markers include platinum, tantalum, and gold plated steel. The markers usually comprise materials that are generally categorized as radiopaque materials that obstruct the transmission of radiant energy, such as the energy emitted from a C-arm radiographic device.
In the arrangement of
Many other variations of the marker arrangements to create any of a number of marker arrangement shapes are possible. For example, in addition to parallelogram shapes, rectangle, rhombus, rhomboid, triangle, trapezoid, and various quadrilaterals shapes are possible marker arrangement shapes.
The markers 18, 19, 22, 23 can be configured as marker bands having a circular cross-section. The markers can also have a semi-circular, oval, or semi-oval cross-section. The markers should have sufficient circumferential shape to be mounted and then stay retained in position when secured to the catheter branch. The markers can be secured to the catheter branches in a variety of ways. For example, the markers can be secured to an outer or inner surface of the catheter branch, or embedded in or otherwise integrated within the sidewall structure of the catheter branch.
The axial spacing between pairs of proximal markers (e.g., markers 19, 23) and distal markers (e.g., markers 18, 22) is another variable that can be adjusted. The axial spacing between the distal ends of markers 22, 23 and the proximal ends of markers 18, 19 in
Referring now to
In order to more clearly distinguish the catheter branch 14, the branch 14 can include a helical coil 24 extending along a portion of a length of the branch 14. The helical coil comprises a visible material such as the radiopaque material described above for use with markers 18, 19, 22, 23. The helical coil 24 extends from the marker 22 to the marker 23. The helical coil can also have different lengths and extend over different portions of the branch 14. For example, the helical coil can have an axial length at least as great as an axial length of the stent being deployed using the catheter branches 12, 14. The helical coil can be positioned on the catheter branch so that it overlaps axially with the stent. In another example, the coil extends axially from near a distal tip of the catheter branch 14 to a proximal end of the stent. For these and other examples, it is assumed that the branch 14 is secured or otherwise fixed axially relative to the main catheter branch 12 at a location proximal of the side opening in the stent through which the side catheter branch 14 extends.
The helical coil 24 can be used in combination with one or more markers on a given catheter branch. The helical coil 24 can also be used by itself on a catheter branch without any other markers on that catheter branch. The helical coil can provide visualization of the catheter branch for at least the purpose of distinguishing the catheter branches 12, 14 from each other. The helical coil can also be useful for positioning the catheter branch to which it is mounted relative to other features of a stent delivery system and vessel bifurcation.
The helical coil 24 can provide certain advantages due to the helical structure. A helical coil can provide for flexibility in a lateral direction relative to an axis of the catheter branch so that the catheter branch maintains its ability to navigate through a vessel to a vessel treatment sight. A helical coil can also be easily mounted to an outer surface of a cylindrical member such as the main and side catheter branches 12, 14. A helical coil can be embedded in a catheter branch using methods such as, for example, co-molding or extrusion techniques.
Other structures can be used in place of the helical coil 24 and provide similar advantages. For example, a braid structure, a plurality interconnected rings, or a thin layer or film can provide at least some of the same advantages and function of a helical coil. Referring to
Referring to
In many embodiments, the distal tips 16, 20 of the catheter branches 12, 14 include some type of marker or marker material composition. Marking the distal tip of a catheter branch can help with determining a relative position of the catheter branch relative to other features of a stent delivery system and features of the vessel through which the catheter branch travels. In one example, a marked distal tip 20 of a side catheter branch 14 can help in determining that the branch 14 has entered the vessel branch of a vessel bifurcation. By providing a length of a catheter branch (e.g., L5) with a marker material that provides visualization along that length, it may be easier to identify cross-over and twisting of the catheter branches 12, 14 relative to each other.
Materials and Other Considerations
The example systems disclosed herein may be used in over-the-wire or rapid exchange systems. Some example rapid exchanges systems are disclosed in U.S. Published Patent Application No. 2003/0181923 to Vardi et al., which application is incorporated herein by reference.
The materials used in the balloons, catheter shafts, and other components of the catheter assemblies disclosed herein can be made of any suitable material including, for example, thermoplastic polymers, polyethylene (high density, low density, intermediate density, linear low density), various co-polymers and blends of polyethylene, ionomers, polyesters, polycarbonates, polyamides, poly-vinyl chloride, acrylonitrile-butadiene-styrene copolymers, polyether-polyester copolymers, and polyetherpolyamide copolymers. One suitable material is Surlyn®, a copolymer polyolefin material (DuPont de Nemours, Wilmington, Del.). Still further suitable materials include thermoplastic polymers and thermoset polymeric materials, poly(ethylene terephthalate) (commonly referred to as PET), thermoplastic polyamide, polyphenylene sulfides, polypropylene. Some other example materials include polyurethanes and block copolymers, such as polyamide-polyether block copolymers or amide-tetramethylene glycol copolymers. Additional examples include the PEBAX® (a polyamide/polyether/polyester block copolymer) family of polymers, e.g., PEBAX® 70D, 72D, 2533, 5533, 6333, 7033, or 7233 (available from Elf AtoChem, Philadelphia, Pa.). Other examples include nylons, such as aliphatic nylons, for example, Vestamid L21011F, Nylon 11 (Elf Atochem), Nylon 6 (Allied Signal), Nylon 6/10 (BASF), Nylon 6/12 (Ashley Polymers), or Nylon 12. Additional examples of nylons include aromatic nylons, such as Grivory (EMS) and Nylon MXD-6. Other nylons and/or combinations of nylons can also be used. Still further examples include polybutylene terephthalate (PBT), such as CELANEX® (available from Ticona, Summit, N.J.), polyester/ether block copolymers such as ARNITEL® (available from DSM, Erionspilla, Ind.), e.g., ARNITEL® EM740, aromatic amides such as Trogamid (PA6-3-T, Degussa), and thermoplastic elastomers such as HYTREL® (Dupont de Nemours, Wilmington, Del.). In some embodiments, the PEBAX®, HYTREL®, and ARNITEL® materials have a Shore D hardness of about 45D to about 82D. The balloon materials can be used pure or as blends. For example, a blend may include a PBT and one or more PBT thermoplastic elastomers, such as RITEFLEX® (available from Ticona), ARNITEL®, or HYTREL®, or polyethylene terephthalate (PET) and a thermoplastic elastomer, such as a PBT thermoplastic elastomer. Additional examples of balloon material can be found in U.S. Pat. No. 6,146,356. It should be understood that the specific materials disclosed below for the individual embodiments does not limit the embodiment to those materials.
In the example catheter assemblies described above, the branch balloon can include a lubricious coating on an exterior surface thereof. The coating can promote insertion of the branch balloon into the branch vessel of a vessel bifurcation. The coating can also improve removal of the branch balloon from the branch vessel and the branch aperture of the stent when deflating and removing the catheter assembly from the vessel bifurcation after expansion of the stent. Some example coating for use with the branch balloon include hydrophilic polymers such as polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxyl alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers can be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coating with suitable lubricity, bonding and solubility. In some examples, portions of the devices described herein can be coated with a hydrophilic polymer or a fluoropolymer such as polytetrafluoroethylene (PTFE), better known as TEFLON®.
While the example stent delivery systems described above illustrate a balloon expandable stent having a predetermined side opening (i.e., branch aperture), other types of stents can be used with the catheter features described above. A variety of stents can be used with the systems and methods disclosed herein. Examples of such stents can be found in, for example, in U.S. Pat. Nos. 6,210,429 and 6,325,826 to Vardi et al., and co-pending U.S. patent application Ser. No. 10/644,550, filed on Aug. 21, 2003, and titled “Stent With a Protruding Branch Portion For Bifurcated Vessels,” the entire contents of which are incorporated herein by reference. In general, the aforementioned stents have a tubular shape with a continuous sidewall that extends between the proximal and distal ends. Proximal and distal stent apertures are defined at respective proximal and distal ends of the stent. A branch aperture is defined in the sidewall of the stent. The branch aperture provides access between an interior of the stent and an exterior of the stent. In some stents, the branch aperture includes expandable structure around a peripheral edge thereof that expands in a generally radial outward direction relative to a longitudinal axis of the stent. The expandable structure can be configured to extend into the branch lumen of the bifurcation upon expansion of the stent. The stent includes a plurality of strut structures that define the sidewall. The struts are expandable from a first, unexpanded state to a second, expanded state. Typically, the stent is configured to maintain the expanded state. The struts define a plurality of cell openings or cells along a length of the stent. The size and shape of the cells is typically different than the size and shape of the branch aperture. The stent is typically expanded once the stent is properly positioned in the main lumen of the bifurcation with the branch aperture aligned radially and axially with an opening into the branch lumen. The stent, including the expandable structure surrounding the branch aperture, can be expanded with a single expansion or with multiple expansions using, for example, one or more inflatable balloons.
Conclusion
One aspect of the present disclosure relates to a catheter assembly that includes a first catheter branch, a second catheter branch, first distal and proximal markers, and second distal and proximal markers. The first catheter branch includes a distal end portion that extends in a first direction. The second catheter branch includes a distal end portion that extends in a second direction that is generally the same direction as the first direction. The first distal marker and the first proximal marker are positioned on the first catheter branch. The second distal marker and the second proximal marker are positioned on the second catheter branch. The first distal marker, the first proximal marker, the second distal marker and the second proximal marker each include a distal portion and a proximal portion. The proximal portion of the first distal marker is positioned distal of the distal portion of the second distal marker, and the distal portion of the first proximal marker is positioned proximal of the proximal portion of the second proximal marker.
Another aspect of the present disclosure relates to a catheter assembly that includes a stent, a first catheter branch, a second catheter branch, first distal and proximal markers, and second distal and proximal markers. The stent includes a proximal open end, a distal open end, and a side opening defined in a sidewall of the stent at a location between the proximal and distal open ends. The first catheter branch includes a distal end portion that extends in a first direction through the side opening of the stent. The second catheter branch includes a distal end portion that extends through the stent between the distal and proximal open ends. The distal end portion of the first catheter extends in a second direction that is generally the same direction as the first direction prior to insertion of the catheter assembly into a body lumen. The first distal marker and the first proximal marker are positioned on the first catheter branch. At least a portion of the first distal marker is positioned distally of the side opening of the stent and the first proximal marker is positioned proximal of the first distal marker. The second distal marker and the second proximal marker are positioned on the second catheter branch. At least a portion of the second distal marker is positioned further proximally than a proximal portion of the first distal marker, and at least a portion of the second proximal marker is positioned further proximally than a proximal portion of the first proximal member.
Another aspect of the present disclosure relates to a catheter assembly that includes a first catheter branch, a second catheter branch, first distal and proximal markers, and second distal and proximal markers. The first catheter branch includes a distal end portion that extends through the stent. The second catheter branch includes a distal end portion that extends through the stent in an adjacent orientation to the distal end portion of the second catheter branch prior to insertion of the catheter assembly into a body lumen. The first distal marker and the first proximal marker are positioned on the first catheter branch at axially spaced apart locations. The second distal marker and a second proximal marker are positioned on the second catheter branch at axially spaced apart locations. The first distal marker and the first proximal marker each have a length that is imageably distinct from a length of each of the second distal marker and the second proximal marker.
A further aspect of the present disclosure relates to a stent delivery system that includes a stent, a main catheter branch, a side catheter branch, main distal and proximal markers, and side distal and proximal markers. The stent includes a distal open end, a proximal open end, and a side opening defined in a sidewall of the stent at a location between the proximal and distal open ends. The main catheter branch includes a balloon member that extends through the stent from the proximal open end to the distal open end. The main catheter branch is configured to advance over a first guidewire to a main vessel of a vessel bifurcation. The side catheter branch extends into the proximal open end of the stent and extends out of the side opening. The side catheter branch is configured to advance over a second guidewire to a branch vessel of the vessel bifurcation. The main distal marker and the main proximal marker are positioned on the main catheter branch, and the side distal marker and the side proximal marker are positioned on the side catheter branch. At least one of the main and side proximal markers is positioned outside of the stent and at least one of the main and side distal markers are positioned outside of the stent. A relative position of the main and side distal markers and the main and side proximal markers provides an indication of relative twist between the main and side catheter branches and alignment of the stent sidewall opening relative to an opening from the main vessel into the branch vessel of the vessel bifurcation.
A further aspect of the present disclosure relates to a stent delivery system that includes a stent, a main catheter branch, and a side catheter branch. The stent includes a distal open end, a proximal open end, and a side opening at a location between the proximal and distal open ends. The main catheter branch includes a balloon member at least partially positioned within the stent, and the main catheter branch is configured to advance over a first guidewire into a main vessel of a vessel bifurcation. The side catheter branch extends through the side opening of the stent and includes marker material along a length of the side catheter branch. The marker material extends along a distal end portion of the side catheter branch and has a length at least as great as a distance from the side opening of the stent to the distal open end of the stent. The side catheter branch is configured to advance over a second guidewire into a branch vessel of the vessel bifurcation.
A still further aspect of the present disclosure relates to a method of treating a vessel bifurcation. The method includes positioning a first guidewire in a main vessel of the vessel bifurcation, positioning a second guidewire in a branch vessel of the vessel bifurcation, advancing a catheter assembly over the first and second guidewires to the vessel bifurcation, wherein the catheter assembly includes a stent, first and second pairs of markers, and first and second catheter members. The first and second catheter members have a fixed axial position relative to each other, and the first and second catheter members extend through portions of the stent. The method further includes observing relative positions of the first and second pair of markers, adjusting a position of the stent relative to the vessel bifurcation based on observed positions of the first and second pairs of markers; and expanding the stent to treat the vessel bifurcation.
The above specification, examples and data provide a complete description of the manufacture and use of the composition of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention resides in the claims hereinafter appended.
This application claims priority to U.S. Provisional Application No. 60/776,149 filed on Feb. 22, 2006, entitled MARKER ARRANGEMENT FOR BIFURCATION CATHETER, the disclosure of which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
1596754 | Moschelle | Aug 1926 | A |
3657744 | Ersek | Apr 1972 | A |
3872893 | Roberts | Mar 1975 | A |
4140126 | Choudhury | Feb 1979 | A |
4309994 | Grunwald | Jan 1982 | A |
4385631 | Uthmann | May 1983 | A |
4410476 | Redding et al. | Oct 1983 | A |
4413989 | Schjeldahl et al. | Nov 1983 | A |
4421810 | Rasmussen | Dec 1983 | A |
4453545 | Inoue | Jun 1984 | A |
4503569 | Dotter | Mar 1985 | A |
4552554 | Gould et al. | Nov 1985 | A |
4681570 | Dalton | Jul 1987 | A |
4689174 | Lupke | Aug 1987 | A |
4731055 | Melinyshyn et al. | Mar 1988 | A |
4733665 | Palmaz | Mar 1988 | A |
4739762 | Palmaz | Apr 1988 | A |
4759748 | Reed | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4769029 | Patel | Sep 1988 | A |
4819664 | Nazari | Apr 1989 | A |
4872874 | Taheri | Oct 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4896670 | Crittenden | Jan 1990 | A |
4900314 | Quackenbush | Feb 1990 | A |
4906244 | Pinchuk et al. | Mar 1990 | A |
4909258 | Kuntz et al. | Mar 1990 | A |
4946464 | Pevsner | Aug 1990 | A |
4957501 | Lahille et al. | Sep 1990 | A |
4957508 | Kaneko et al. | Sep 1990 | A |
4964850 | Bouton et al. | Oct 1990 | A |
4983167 | Sahota | Jan 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
5042976 | Ishitsu et al. | Aug 1991 | A |
5054501 | Chuttani et al. | Oct 1991 | A |
5059170 | Cameron | Oct 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5061240 | Cherian | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5085664 | Bozzo | Feb 1992 | A |
5102403 | Alt | Apr 1992 | A |
5102417 | Palmaz | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5117831 | Jang et al. | Jun 1992 | A |
5122125 | Deuss | Jun 1992 | A |
5135536 | Hillstead | Aug 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5159920 | Condon et al. | Nov 1992 | A |
5176617 | Fischell et al. | Jan 1993 | A |
5192297 | Hull | Mar 1993 | A |
5195984 | Schatz | Mar 1993 | A |
5211683 | Maginot | May 1993 | A |
5217440 | Frassica | Jun 1993 | A |
5222971 | Willard et al. | Jun 1993 | A |
5226913 | Pinchuk | Jul 1993 | A |
5234457 | Andersen | Aug 1993 | A |
5236446 | Dumon | Aug 1993 | A |
5244619 | Burnham | Sep 1993 | A |
5254619 | Ando | Oct 1993 | A |
5257974 | Cox | Nov 1993 | A |
5263932 | Jang | Nov 1993 | A |
5282472 | Companion et al. | Feb 1994 | A |
5304220 | Maginot | Apr 1994 | A |
5320605 | Sahota | Jun 1994 | A |
5324257 | Osborne et al. | Jun 1994 | A |
5337733 | Bauerfeind et al. | Aug 1994 | A |
5338300 | Cox | Aug 1994 | A |
5342295 | Imran | Aug 1994 | A |
5342297 | Jang | Aug 1994 | A |
5342387 | Summers | Aug 1994 | A |
5350395 | Yock | Sep 1994 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5395332 | Ressemann et al. | Mar 1995 | A |
5395334 | Keith et al. | Mar 1995 | A |
5404887 | Prather | Apr 1995 | A |
5409458 | Khairkhahan et al. | Apr 1995 | A |
5413581 | Goy | May 1995 | A |
5413586 | Dibie et al. | May 1995 | A |
5417208 | Winkler | May 1995 | A |
5425765 | Tiefenbrun et al. | Jun 1995 | A |
5437638 | Bowman | Aug 1995 | A |
5443497 | Venbrux | Aug 1995 | A |
5445624 | Jimenez | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5449382 | Dayton | Sep 1995 | A |
5456694 | Marin et al. | Oct 1995 | A |
5456712 | Maginot | Oct 1995 | A |
5456714 | Owen | Oct 1995 | A |
5458605 | Klemm | Oct 1995 | A |
5462530 | Jang | Oct 1995 | A |
5476471 | Shifrin et al. | Dec 1995 | A |
5489271 | Andersen | Feb 1996 | A |
5489295 | Piplani et al. | Feb 1996 | A |
5496292 | Burnham | Mar 1996 | A |
5505702 | Arney | Apr 1996 | A |
5507768 | Lau et al. | Apr 1996 | A |
5507769 | Marin et al. | Apr 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5514178 | Torchio | May 1996 | A |
5522801 | Wang | Jun 1996 | A |
5531788 | Dibie et al. | Jul 1996 | A |
5545132 | Fagan et al. | Aug 1996 | A |
5549553 | Ressemann et al. | Aug 1996 | A |
5549554 | Miraki | Aug 1996 | A |
5562620 | Klein et al. | Oct 1996 | A |
5562724 | Vorwerk et al. | Oct 1996 | A |
5562725 | Schmitt et al. | Oct 1996 | A |
5562726 | Chuter | Oct 1996 | A |
5569295 | Lam | Oct 1996 | A |
5571087 | Ressemann et al. | Nov 1996 | A |
5575771 | Walinsky | Nov 1996 | A |
5575817 | Martin | Nov 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5591228 | Edoga | Jan 1997 | A |
5593442 | Klein | Jan 1997 | A |
5607444 | Lam | Mar 1997 | A |
5609605 | Marshall et al. | Mar 1997 | A |
5609625 | Piplani et al. | Mar 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5609629 | Fearnot et al. | Mar 1997 | A |
5613949 | Miraki | Mar 1997 | A |
5613980 | Chauhan | Mar 1997 | A |
5613981 | Boyle et al. | Mar 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5626600 | Horzewski et al. | May 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5632762 | Myler | May 1997 | A |
5632763 | Glastra | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5634902 | Johnson et al. | Jun 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5643340 | Nunokawa | Jul 1997 | A |
5653743 | Martin | Aug 1997 | A |
5662614 | Edoga | Sep 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5669932 | Fischell et al. | Sep 1997 | A |
5676696 | Marcade | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5679400 | Tuch | Oct 1997 | A |
5683451 | Lenker et al. | Nov 1997 | A |
5690642 | Osborne et al. | Nov 1997 | A |
5693084 | Chuter | Dec 1997 | A |
5693086 | Goicoechea et al. | Dec 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5707354 | Salmon et al. | Jan 1998 | A |
5709713 | Evans et al. | Jan 1998 | A |
5716365 | Goicoechea et al. | Feb 1998 | A |
5718683 | Ressemann et al. | Feb 1998 | A |
5718724 | Goicoechea et al. | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5723004 | Dereume et al. | Mar 1998 | A |
5724977 | Yock et al. | Mar 1998 | A |
5728158 | Lau et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5735893 | Lau et al. | Apr 1998 | A |
5746766 | Edoga | May 1998 | A |
5749825 | Fischell et al. | May 1998 | A |
5749848 | Jang et al. | May 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5755735 | Richter et al. | May 1998 | A |
5755770 | Ravenscroft | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5762631 | Klein | Jun 1998 | A |
5776101 | Goy | Jul 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776180 | Goicoechea et al. | Jul 1998 | A |
5782906 | Marshall et al. | Jul 1998 | A |
5800450 | Lary et al. | Sep 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5814061 | Osborne et al. | Sep 1998 | A |
5817126 | Imran | Oct 1998 | A |
5824008 | Bolduc et al. | Oct 1998 | A |
5824036 | Lauterjung | Oct 1998 | A |
5824039 | Piplani et al. | Oct 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5824042 | Lombardi et al. | Oct 1998 | A |
5824044 | Quiachon et al. | Oct 1998 | A |
5827320 | Richter et al. | Oct 1998 | A |
5833650 | Imran | Nov 1998 | A |
5836966 | St. Germain | Nov 1998 | A |
5837008 | Berg et al. | Nov 1998 | A |
5843031 | Hermann et al. | Dec 1998 | A |
5843160 | Rhodes | Dec 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5846204 | Solomon | Dec 1998 | A |
5851210 | Torossian | Dec 1998 | A |
5851464 | Davila et al. | Dec 1998 | A |
5855600 | Alt | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5865178 | Yock | Feb 1999 | A |
5868777 | Lam | Feb 1999 | A |
5871536 | Lazarus | Feb 1999 | A |
5871537 | Holman et al. | Feb 1999 | A |
5891133 | Murphy-Chutorian | Apr 1999 | A |
5897588 | Hull et al. | Apr 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5907893 | Zadno-Azizi et al. | Jun 1999 | A |
5913895 | Burpee et al. | Jun 1999 | A |
5913897 | Corso, Jr. et al. | Jun 1999 | A |
5921958 | Ressemann et al. | Jul 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
5928248 | Acker | Jul 1999 | A |
5938682 | Hojeibane et al. | Aug 1999 | A |
5938696 | Goicoechea et al. | Aug 1999 | A |
5948016 | Jang | Sep 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5967986 | Cimochowski et al. | Oct 1999 | A |
5972018 | Israel et al. | Oct 1999 | A |
6007517 | Anderson | Dec 1999 | A |
6013054 | Jiun Yan | Jan 2000 | A |
6013091 | Ley et al. | Jan 2000 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6017324 | Tu et al. | Jan 2000 | A |
6017363 | Hojeibane | Jan 2000 | A |
6024763 | Lenker et al. | Feb 2000 | A |
6030414 | Taheri | Feb 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6036682 | Lange et al. | Mar 2000 | A |
6039749 | Marin et al. | Mar 2000 | A |
6042597 | Kveen et al. | Mar 2000 | A |
6045557 | White et al. | Apr 2000 | A |
6048361 | Von Oepen | Apr 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6059823 | Holman et al. | May 2000 | A |
6059824 | Taheri | May 2000 | A |
6066168 | Lau et al. | May 2000 | A |
6068655 | Seguin et al. | May 2000 | A |
6071285 | Lashinski et al. | Jun 2000 | A |
6086611 | Duffy et al. | Jul 2000 | A |
6090127 | Globerman | Jul 2000 | A |
6090128 | Douglas | Jul 2000 | A |
6096073 | Webster et al. | Aug 2000 | A |
6099497 | Adams et al. | Aug 2000 | A |
6102938 | Evans et al. | Aug 2000 | A |
6117117 | Mauch | Sep 2000 | A |
6117156 | Richter et al. | Sep 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6129738 | Lashinski et al. | Oct 2000 | A |
6129754 | Kanesaka et al. | Oct 2000 | A |
6142973 | Carleton et al. | Nov 2000 | A |
6146356 | Wang et al. | Nov 2000 | A |
6152945 | Bachinski et al. | Nov 2000 | A |
6165195 | Wilson et al. | Dec 2000 | A |
6165197 | Yock | Dec 2000 | A |
6165214 | Lazarus | Dec 2000 | A |
6179867 | Cox | Jan 2001 | B1 |
6183506 | Penn et al. | Feb 2001 | B1 |
6183509 | Dibie | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6190403 | Fischell et al. | Feb 2001 | B1 |
6193746 | Strecker | Feb 2001 | B1 |
6203568 | Lombardi et al. | Mar 2001 | B1 |
6203569 | Wijay | Mar 2001 | B1 |
6210380 | Mauch | Apr 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6217608 | Penn et al. | Apr 2001 | B1 |
6221080 | Power | Apr 2001 | B1 |
6221090 | Wilson | Apr 2001 | B1 |
6221098 | Wilson et al. | Apr 2001 | B1 |
6231563 | White et al. | May 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6231600 | Zhong | May 2001 | B1 |
6235051 | Murphy | May 2001 | B1 |
6241762 | Shanley | Jun 2001 | B1 |
6251133 | Richter et al. | Jun 2001 | B1 |
6258073 | Mauch | Jul 2001 | B1 |
6258099 | Mareiro et al. | Jul 2001 | B1 |
6258116 | Hojeibane | Jul 2001 | B1 |
6258121 | Yang et al. | Jul 2001 | B1 |
6261273 | Ruiz | Jul 2001 | B1 |
6261305 | Marotta et al. | Jul 2001 | B1 |
6261319 | Kveen et al. | Jul 2001 | B1 |
6264682 | Wilson et al. | Jul 2001 | B1 |
6273911 | Cox et al. | Aug 2001 | B1 |
6273913 | Wright et al. | Aug 2001 | B1 |
6287314 | Lee et al. | Sep 2001 | B1 |
6290673 | Shanley | Sep 2001 | B1 |
6293967 | Shanley | Sep 2001 | B1 |
6299634 | Bergeron | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6309412 | Lau et al. | Oct 2001 | B1 |
6309414 | Rolando et al. | Oct 2001 | B1 |
6312459 | Huang et al. | Nov 2001 | B1 |
6325821 | Gaschino et al. | Dec 2001 | B1 |
6325826 | Vardi et al. | Dec 2001 | B1 |
6334870 | Ehr et al. | Jan 2002 | B1 |
6346089 | Dibie | Feb 2002 | B1 |
6350278 | Lenker et al. | Feb 2002 | B1 |
6355060 | Lenker et al. | Mar 2002 | B1 |
6361544 | Wilson et al. | Mar 2002 | B1 |
6361555 | Wilson | Mar 2002 | B1 |
6371978 | Wilson | Apr 2002 | B1 |
6383213 | Wilson et al. | May 2002 | B2 |
6383215 | Sass | May 2002 | B1 |
6387120 | Wilson et al. | May 2002 | B2 |
6395018 | Castaneda | May 2002 | B1 |
6398792 | O'Connor | Jun 2002 | B1 |
6398804 | Spielberg | Jun 2002 | B1 |
6428567 | Wilson et al. | Aug 2002 | B2 |
6428570 | Globerman | Aug 2002 | B1 |
6432133 | Lau et al. | Aug 2002 | B1 |
6436104 | Hojeibane | Aug 2002 | B2 |
6436134 | Richter et al. | Aug 2002 | B2 |
6468302 | Cox et al. | Oct 2002 | B2 |
6475208 | Mauch | Nov 2002 | B2 |
6478816 | Kveen et al. | Nov 2002 | B1 |
6482211 | Choi | Nov 2002 | B1 |
6485511 | Lau et al. | Nov 2002 | B2 |
6494905 | Zedler et al. | Dec 2002 | B1 |
6508836 | Wilson et al. | Jan 2003 | B2 |
6511504 | Lau et al. | Jan 2003 | B1 |
6511505 | Cox et al. | Jan 2003 | B2 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6527799 | Shanley | Mar 2003 | B2 |
6540719 | Bigus et al. | Apr 2003 | B2 |
6540779 | Richter et al. | Apr 2003 | B2 |
6572647 | Supper et al. | Jun 2003 | B1 |
6576009 | Ryan et al. | Jun 2003 | B2 |
6579309 | Loos et al. | Jun 2003 | B1 |
6579312 | Wilson et al. | Jun 2003 | B2 |
6582394 | Reiss et al. | Jun 2003 | B1 |
6582459 | Lau et al. | Jun 2003 | B1 |
6596020 | Vardi et al. | Jul 2003 | B2 |
6596022 | Lau et al. | Jul 2003 | B2 |
6599315 | Wilson | Jul 2003 | B2 |
6599316 | Vardi et al. | Jul 2003 | B2 |
6602284 | Cox et al. | Aug 2003 | B2 |
6641609 | Globerman | Nov 2003 | B2 |
6645241 | Strecker | Nov 2003 | B1 |
6652573 | von Oepen | Nov 2003 | B2 |
6669717 | Marotta et al. | Dec 2003 | B2 |
6676667 | Mareiro et al. | Jan 2004 | B2 |
6679911 | Burgermeister | Jan 2004 | B2 |
6682536 | Vardi et al. | Jan 2004 | B2 |
6689156 | Davidson et al. | Feb 2004 | B1 |
6692483 | Vardi et al. | Feb 2004 | B2 |
6695877 | Brucker et al. | Feb 2004 | B2 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6709440 | Matin et al. | Mar 2004 | B2 |
6736841 | Musbach et al. | May 2004 | B2 |
6770092 | Richter | Aug 2004 | B2 |
6780174 | Mauch | Aug 2004 | B2 |
6802856 | Wilson | Oct 2004 | B2 |
6827735 | Greenberg | Dec 2004 | B2 |
6827736 | Perouse | Dec 2004 | B2 |
6843803 | Ryan et al. | Jan 2005 | B2 |
6852124 | Cox et al. | Feb 2005 | B2 |
6855125 | Shanley | Feb 2005 | B2 |
6884258 | Vardi et al. | Apr 2005 | B2 |
6890349 | McGuckin, Jr. et al. | May 2005 | B2 |
6896699 | Wilson et al. | May 2005 | B2 |
6908477 | McGuckin, Jr. et al. | Jun 2005 | B2 |
6942689 | Majercak | Sep 2005 | B2 |
6955687 | Richter et al. | Oct 2005 | B2 |
6955688 | Wilson et al. | Oct 2005 | B2 |
6962602 | Vardi et al. | Nov 2005 | B2 |
6980174 | Flasza et al. | Dec 2005 | B2 |
7018400 | Lashinski et al. | Mar 2006 | B2 |
7056323 | Mareiro et al. | Jun 2006 | B2 |
7105019 | Hojeibane | Sep 2006 | B2 |
7118593 | Davidson et al. | Oct 2006 | B2 |
7125419 | Sequin et al. | Oct 2006 | B2 |
7163553 | Limon | Jan 2007 | B2 |
7238197 | Sequin et al. | Jul 2007 | B2 |
7244853 | Schreiber et al. | Jul 2007 | B2 |
7252679 | Fischell et al. | Aug 2007 | B2 |
7344514 | Shanley | Mar 2008 | B2 |
7387639 | Bourang et al. | Jun 2008 | B2 |
20010037146 | Lau et al. | Nov 2001 | A1 |
20010039448 | Dibie | Nov 2001 | A1 |
20020013618 | Marotta et al. | Jan 2002 | A1 |
20020032478 | Boekstegers et al. | Mar 2002 | A1 |
20020058990 | Jang | May 2002 | A1 |
20020123790 | White et al. | Sep 2002 | A1 |
20020156516 | Vardi et al. | Oct 2002 | A1 |
20020165604 | Shanley | Nov 2002 | A1 |
20020193872 | Trout, III et al. | Dec 2002 | A1 |
20020193873 | Brucker et al. | Dec 2002 | A1 |
20030009209 | Hojelbane | Jan 2003 | A1 |
20030009214 | Shanley | Jan 2003 | A1 |
20030014102 | Hong et al. | Jan 2003 | A1 |
20030114911 | Lupton | Jun 2003 | A1 |
20030125802 | Callol et al. | Jul 2003 | A1 |
20030181923 | Vardi | Sep 2003 | A1 |
20040015227 | Vardi et al. | Jan 2004 | A1 |
20040049259 | Strecker | Mar 2004 | A1 |
20040138737 | Davidson et al. | Jul 2004 | A1 |
20040148006 | Davidson et al. | Jul 2004 | A1 |
20050015108 | Williams et al. | Jan 2005 | A1 |
20050075722 | Chuter | Apr 2005 | A1 |
20050209673 | Shaked | Sep 2005 | A1 |
20050245941 | Vardi et al. | Nov 2005 | A1 |
20070112407 | Mertens et al. | May 2007 | A1 |
20070179591 | Baker et al. | Aug 2007 | A1 |
20070288082 | Williams | Dec 2007 | A1 |
20080255581 | Bourang et al. | Oct 2008 | A1 |
Number | Date | Country |
---|---|---|
2318314 | Jul 1999 | CA |
2403826 | Sep 2001 | CA |
9014845.2 | Sep 1991 | DE |
29701758 | May 1997 | DE |
60036233 | May 2008 | DE |
0891751 | Jan 1999 | EP |
0897700 | Feb 1999 | EP |
0904745 | Mar 1999 | EP |
1031328 | Aug 2000 | EP |
0884028 | Feb 2002 | EP |
0646365 | Jan 2004 | EP |
0684022 | Feb 2004 | EP |
0897698 | Jun 2004 | EP |
1182989 | Dec 2004 | EP |
1 512 380 | Mar 2005 | EP |
0551179 | Apr 2005 | EP |
1157674 | Jul 2005 | EP |
0804907 | Nov 2005 | EP |
1031330 | Nov 2005 | EP |
0876805 | Aug 2006 | EP |
2678508 | Jan 1993 | FR |
8-299456 | Nov 1996 | JP |
WO 8806026 | Aug 1988 | WO |
WO 9013332 | Nov 1990 | WO |
WO 9112779 | Sep 1991 | WO |
WO 9219308 | Nov 1992 | WO |
WO 9508965 | Apr 1995 | WO |
WO 9521592 | Aug 1995 | WO |
WO 9629955 | Oct 1996 | WO |
WO 9634580 | Nov 1996 | WO |
WO 9641592 | Dec 1996 | WO |
WO 9709946 | Mar 1997 | WO |
WO 9716217 | May 1997 | WO |
WO 9726936 | Jul 1997 | WO |
WO 9732544 | Sep 1997 | WO |
WO 9733532 | Sep 1997 | WO |
WO 9741802 | Nov 1997 | WO |
WO 9745073 | Dec 1997 | WO |
WO 9817204 | Apr 1998 | WO |
9819628 | May 1998 | WO |
WO 9835634 | Aug 1998 | WO |
WO 9836709 | Aug 1998 | WO |
WO 9837833 | Sep 1998 | WO |
WO 9844871 | Oct 1998 | WO |
WO 9848733 | Nov 1998 | WO |
WO 9852497 | Nov 1998 | WO |
WO 9900835 | Jan 1999 | WO |
WO 9915103 | Apr 1999 | WO |
WO 9917680 | Apr 1999 | WO |
WO 9934749 | Jul 1999 | WO |
WO 9935979 | Jul 1999 | WO |
WO 9936002 | Jul 1999 | WO |
WO 9939661 | Aug 1999 | WO |
WO 9949793 | Oct 1999 | WO |
WO 9958059 | Nov 1999 | WO |
WO 9965419 | Dec 1999 | WO |
WO 0000104 | Jan 2000 | WO |
WO 0012166 | Mar 2000 | WO |
WO 0013613 | Mar 2000 | WO |
WO 0053122 | Sep 2000 | WO |
WO 0074595 | Dec 2000 | WO |
WO 0121095 | Mar 2001 | WO |
WO 0121109 | Mar 2001 | WO |
WO 0121244 | Mar 2001 | WO |
WO 0170299 | Sep 2001 | WO |
WO 02068012 | Sep 2002 | WO |
WO 02076333 | Oct 2002 | WO |
WO 02094336 | Nov 2002 | WO |
WO 03055414 | Jul 2003 | WO |
WO 2004026180 | Apr 2004 | WO |
WO 2005107643 | Nov 2005 | WO |
WO 2005107643 | Nov 2005 | WO |
WO 2006033126 | Mar 2006 | WO |
WO 2006124162 | Nov 2006 | WO |
WO 2007100672 | Sep 2007 | WO |
Entry |
---|
Caputo et al., “Stent Jail: A Minimum-Security Prison,” The American Journal of Cardiology, vol. 77, pp. 1226-1230, Jun. 1, 1996. |
Carrie et al., ““T”—Shaped Stent Placement: A Technique for the Treatment of Dissected Bifurcation Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 37, pp. 311-313, 1996. |
Chevalier et al., “Placement of Coronary Stents in Bifurcation Lesions by the “Culotte” Technique,” The American Journal of Cardiology, vol. 82, pp. 943-949, Oct. 15, 1998. |
Colombo et al., ““Kissing” Stents for Bifurcational Coronary Lesion,” Catheterization and Cardiovascular Diagnosis, vol. 30, pp. 327-330, 1993. |
U.S. Appl. No. 08/642,297, filed May 3, 1996, to Richter et al. |
U.S. Appl. No. 09/325,996, filed Jun. 4, 1999, to Vardi et al. |
U.S. Appl. No. 09/533,616, filed Mar. 22, 2000, to Vardi et al. |
U.S. Appl. No. 09/614,472, filed Jul. 11, 2000, to Davidson et al. |
U.S. Appl. No. 09/663,111, filed Sep. 15, 2000, to Davidson et al. |
Dichek et al., “Seeding of Intravascular Stents with Genetically Engineered Endothelial Cells,” Circulation, vol. 80, No. 5, pp. 1347-1353, Nov. 1989. |
Fischman et al., “A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease,” New England Journal of Medicine, vol. 331, No. 8, pp. 496-501, Aug. 25, 1994. |
Katoh et al., “New Double Wire Technique to Stent Ostial Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 40, pp. 400-402, 1997. |
Lear et al., “The Northridge Earthquake as a Trigger for Acute Myocardial Infarction,” 1 page, 1996. |
Lewis et al., “Acute Procedural Results in the Treatment of 30 Coronary Artery Bifurcation Lesions with a Double-Wire Atherectomy Technique for Side-Branch Protection,” American Heart Journal, vol. 127, No. 6, pp. 1600-1607, 1994. |
Nakamura et al., “Techniques for Palmaz-Schatz Stent Deployment in Lesions with a Large Side Branch,” Catheterization and Cardiovascular Diagnosis, vol. 34, pp. 353-361, 1995. |
Satler et al. “Bifurcation Disease: To Treat or Not to Treat,” Catheterization and Cardiovascular Interventions, vol. 50, pp. 411-412, 2000. |
SCIMED Life Systems, Inc., “TRIO 14 PTCA Catheter, Re-Engineering Over-The-Wire Balloon Technology,” Brochure, 4 pages, 1994. |
Serruys et al., “A Comparison of Balloon Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease,” The New England Journal of Medicine, vol. 331, No. 8, pp. 489-495, Aug. 25, 1994. |
Yamashita et al., “Bifurcation Lesions: Two Stents Versus One Stent—Immediate and Follow-up Results,” Journal of the American College of Cardiology, vol. 35, No. 5, pp. 1145-1151, Apr. 2000. |
Number | Date | Country | |
---|---|---|---|
20070203562 A1 | Aug 2007 | US |
Number | Date | Country | |
---|---|---|---|
60766149 | Feb 2006 | US |